Form 4 for CVS CVS Health
Accepted 2026-04-02 16:55:05 ET · period of report 2026-03-31 · accession 0000064803-26-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-02 16:55 | 2026-03-31 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | A - Grant | $71.82 | +22.3K | 88.5K | +34% | +$1.60M |
| D | 2026-04-02 16:55 | 2026-04-01 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | F - Tax | $72.49 | -3,634 | 79.7K | -4% | -$263.4K |
| D | 2026-04-02 16:55 | 2026-03-31 | CVS | Mandadi Tilak | EVP, Chief Exp, Tech Off | A - Grant | $71.82 | +143.7K | 143.7K | New | +$10.32M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSUs) | 2026-03-31 | A | A | 22,277 | $71.82 | 88,543 | D | — | — | (F1) Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| 2 | Common | Common Stock | 2026-04-01 | F | D | 3,634 | $72.49 | 79,684 | D | — | — | (F2) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |
| 3 | Derivative | Stock Option | 2026-03-31 | A | A | 143,712 | $71.82 | 143,712 | D | $71.82 · 2027-03-31 to 2036-03-31 | 143,712 Common Stock | (F3) Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |